BOULDER, Colo. — The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of Chindex International Inc. (“Chindex” or the “Company”) (Nasdaq: CHDX).
The Firm’s investigation relates to the announcement that Chindex had entered into an agreement to be acquired by a consortium of buyers, which includes an affiliate of TPG Capital (a private equity firm), Shanghai Fosun Pharmaceutical Group and Chindex founder, President and Chief Executive Officer Roberta Lipson. Under the terms of the agreement, public shareholders of Chindex will receive $19.50 per share in cash for each share of Chindex they own. The investigation concerns whether the Chindex Board of Directors violated its fiduciary duties by agreeing to the proposed transaction and whether the proposed consideration adequately values Chindex’s common stock.
If you currently own Chindex common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Kip B. Shuman or Rusty E. Glenn toll free at (866) 974-8626 or email Mr. Shuman at firstname.lastname@example.org or email Mr. Glenn at email@example.com.
The Shuman Law Firm represents investors throughout the nation, concentrating its practice in stockholder litigation.